Avian reovirus activates a novel proapoptotic signal by linking Src to p53

Lin Ping-Yuan1, Liu Hung-Jen, Lai Meng-Jiun

  • 1Graduate Institute and Department of Life Science, Tzu-Chi University, 701, Sec. 3, Chung-Yang Rd., Hualien, Taiwan, 970.

Insights

Avian reovirus (ARV) S1133 infection activates Src and p53 signaling pathways, leading to apoptosis. The viral protein sigmaC utilizes this p53-dependent pathway to induce programmed cell death.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • Avian reovirus (ARV) S1133 and its protein sigmaC induce apoptosis in Vero cells via an unknown pathway.
  • Understanding the molecular mechanisms of ARV-induced apoptosis is crucial for viral pathogenesis research.

Purpose of the Study:

  • To elucidate the intracellular signaling pathway by which ARV S1133 induces proapoptotic signals.
  • To investigate the role of Src and p53 in ARV-induced apoptosis.

Main Methods:

  • ARV S1133 infection of cultured Vero cells.
  • Analysis of p53 and Src phosphorylation, mRNA, and protein levels.
  • Reporter gene assays for p53 activity.
  • Over-expression of dominant-negative p53, C-terminal Src kinase (Csk), and sigmaC.
  • Treatment with tyrosine kinase inhibitors (genistein, SU-6656).

Main Results:

  • ARV S1133 infection increased p53 and Src phosphorylation, p53 mRNA/protein levels, and bax expression.
  • UV-inactivated virus did not induce apoptosis or activate Src/p53.
  • Inhibition of p53 or Src signaling pathways protected cells from ARV-induced apoptosis.
  • Over-expression of sigmaC upregulated p53, induced p53 phosphorylation, and increased bax levels, mimicking ARV infection effects.

Conclusions:

  • Viral gene expression is essential for ARV S1133 to initiate apoptosis through Src and p53.
  • The viral protein sigmaC plays a key role in triggering apoptosis via a p53-dependent pathway.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...